DAKTARIN GOLD

Ketoconazole cream is for use in adults. For the treatment of tinea pedis (athlete’s foot) and tinea cruris (dhobie itch) and candidal intertrigo (sweat rash).

Tinea cruris, candidal intertrigo and tinea pedis:

It is recommended that Daktarin Gold 2% Cream be applied once or twice daily to cover the affected and immediate surrounding area. The usual duration of treatment is tinea cruris 2-4 weeks, candidal intertrigo 2- 4 weeks, tinea pedis 4-6 weeks.

1 Draft BV 3000 Treatment should be continued, until a few days after disappearance of all symptoms. The diagnosis should be reconsidered if no clinical improvement is noted after 4 weeks of treatment.

Method of administration:

Cutaneous use. Paediatric patients The safety and efficacy of Daktarin Gold 2% Cream in children (17 years and younger) has not been established.

The safety of ketoconazole cream was evaluated in 1079 subjects who participated in 30 clinical trials. Ketoconazole cream was applied topically to the skin. 9%), and application site erythema (1%). Including the above-mentioned adverse drug reactions (ADRs), the following table displays ADRs that have been reported with the use of ketoconazole cream from either clinical trial or postmarketing experiences.

1 Draft BV 3000 Very Common (≥1/10) Common (≥1/100 to <1/10) Uncommon (≥1/1,000 to <1/100) Rare (≥1/10,000 to <1/1,000) Very rare (<1/10,000) Not Known (cannot be estimated from the available clinical trial data). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.

It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Daktarin Gold 2% cream is not for ophthalmic use. To prevent a rebound effect after stopping a prolonged treatment with topical corticosteroids it is recommended to continue applying a mild topical corticosteroid in the morning and to apply Daktarin Gold 2% cream in the evening, and to subsequently and gradually withdraw the steroid therapy over a period of 2-3 weeks.

g. contact dermatitis). Also contains propylene glycol which may cause skin irritation.

1